Phase II prevention trial of celecoxib in women at increased risk for breast cancer

被引：0
|
作者：
Arun, B.
Logan, C.
Yin, G.
Yun, G.
Hortobagyi, G. G.
Browne, D.
Sneige, N.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1501
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Reducing the risk of breast cancer with tamoxifen in women at increased risk
    Vogel, VG
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 87S - 92S
  • [32] Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer
    Banu K. Arun
    Yun Gong
    Diane Liu
    Jennifer K. Litton
    Angelica M. Gutierrez-Barrera
    J. Jack Lee
    Lana Vornik
    Nuhad K. Ibrahim
    Terri Cornelison
    Gabriel N. Hortobagyi
    Brandy M. Heckman-Stoddard
    Kimberly B. Koenig
    Ricardo R. Alvarez
    James L. Murray
    Vicente Valero
    Scott M. Lippman
    Powel Brown
    Nour Sneige
    Breast Cancer Research and Treatment, 2016, 158 : 67 - 77
  • [33] Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial
    Cushman, M
    Costantino, JP
    Bovill, EG
    Wickerham, DL
    Buckley, L
    Roberts, JD
    Krag, DN
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) : 109 - 116
  • [34] Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer
    Arun, Banu K.
    Gong, Yun
    Liu, Diane
    Litton, Jennifer K.
    Gutierrez-Barrera, Angelica M.
    Lee, J. Jack
    Vornik, Lana
    Ibrahim, Nuhad K.
    Cornelison, Terri
    Hortobagyi, Gabriel N.
    Heckman-Stoddard, Brandy M.
    Koenig, Kimberly B.
    Alvarez, Ricardo R.
    Murray, James L.
    Valero, Vicente
    Lippman, Scott M.
    Brown, Powel
    Sneige, Nour
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) : 67 - 77
  • [35] Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial
    Ferrari, V
    Valcamonico, F
    Amoroso, V
    Simoncini, E
    Vassalli, L
    Marpicati, P
    Rangoni, G
    Grisanti, S
    Tiberio, GAM
    Nodari, F
    Strina, C
    Marini, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) : 185 - 190
  • [36] A phase II trial of celecoxib, irinotecan, and capecitabine in metastatic colorectal cancer.
    El-Rayes, BF
    Zalupski, MM
    Shields, AF
    Heilbrun, LK
    Bekaii-Saab, T
    Vaishampayan, U
    Philip, PA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 290S - 290S
  • [37] Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer
    Lipton, Allan
    Campbell-Baird, Cynthia
    Witters, Lois
    Harvey, Harold
    Ali, Suhail
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (04) : 286 - 288
  • [38] Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial
    Vittorio Ferrari
    Francesca Valcamonico
    Vito Amoroso
    Edda Simoncini
    Lucia Vassalli
    Patrizia Marpicati
    Giovanni Rangoni
    Salvatore Grisanti
    Guido AM Tiberio
    Franco Nodari
    Carla Strina
    Giovanni Marini
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 185 - 190
  • [39] Breast density and metabolic risk factors: Cross-sectional analysis of the baseline data from a phase II breast cancer prevention trial
    Trujillo, Jesse
    Tapia, Edgar
    Villa-Guillen, Diana
    Chalasani, Pavani
    Thomson, Cynthia
    Altbach, Maria
    Galons, Jean-Phillipe
    Martinez, Jessica
    Roe, Denise
    Algotar, Amit
    Chow, H. H. Sherry
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [40] MRI for screening women with an increased risk of breast cancer
    Kuhl, C.
    EJC SUPPLEMENTS, 2004, 2 (03): : 53 - 53
12345